1. Home
  2. THRD vs XPOF Comparison

THRD vs XPOF Comparison

Compare THRD & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • XPOF
  • Stock Information
  • Founded
  • THRD 2019
  • XPOF 2017
  • Country
  • THRD United States
  • XPOF United States
  • Employees
  • THRD N/A
  • XPOF N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • THRD Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • THRD Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • THRD 335.2M
  • XPOF 388.8M
  • IPO Year
  • THRD 2022
  • XPOF 2021
  • Fundamental
  • Price
  • THRD $6.00
  • XPOF $15.94
  • Analyst Decision
  • THRD Strong Buy
  • XPOF Buy
  • Analyst Count
  • THRD 3
  • XPOF 9
  • Target Price
  • THRD $20.33
  • XPOF $17.61
  • AVG Volume (30 Days)
  • THRD 248.2K
  • XPOF 365.2K
  • Earning Date
  • THRD 11-07-2024
  • XPOF 02-27-2025
  • Dividend Yield
  • THRD N/A
  • XPOF N/A
  • EPS Growth
  • THRD N/A
  • XPOF N/A
  • EPS
  • THRD N/A
  • XPOF N/A
  • Revenue
  • THRD N/A
  • XPOF $326,724,000.00
  • Revenue This Year
  • THRD N/A
  • XPOF $1.79
  • Revenue Next Year
  • THRD N/A
  • XPOF $7.52
  • P/E Ratio
  • THRD N/A
  • XPOF N/A
  • Revenue Growth
  • THRD N/A
  • XPOF 9.00
  • 52 Week Low
  • THRD $5.60
  • XPOF $7.40
  • 52 Week High
  • THRD $16.94
  • XPOF $18.95
  • Technical
  • Relative Strength Index (RSI)
  • THRD 23.75
  • XPOF 60.55
  • Support Level
  • THRD $5.60
  • XPOF $15.46
  • Resistance Level
  • THRD $11.78
  • XPOF $16.54
  • Average True Range (ATR)
  • THRD 0.89
  • XPOF 0.81
  • MACD
  • THRD -0.43
  • XPOF 0.20
  • Stochastic Oscillator
  • THRD 6.50
  • XPOF 84.46

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix, a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: